Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Image 2_Serum creatinine-to-cystatin C ratio and 1-year mortality risk in advanced breast cancer patients: a multicenter retrospective cohort study.tif

Background<p>Muscle wasting and sarcopenia in advanced breast cancer correlates with poor outcomes. The serum creatinine-to-cystatin C ratio (CCR) is a potential muscle mass biomarker, but its prognostic value in advanced breast cancer is unclear.</p>Methods<p>This multicenter retr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Huijie Deng (5664421) (author)
Autres auteurs: Jiacheng Yang (4867897) (author), Guanyu Zheng (602277) (author), Biyao Zhang (3160059) (author), Yuzhou Wang (600730) (author), Yuye Wu (22381971) (author), Shufen Mo (21743543) (author), Shengchao Huang (22686392) (author), Yuanqi Zhang (18483375) (author), Lixia Li (407712) (author)
Publié: 2025
Sujets:
Clinical and Sports Nutrition
breast cancer
creatinine
cystatin C
creatinine–cystatin C
muscle mass
sarcopenia
mortality
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires